{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:12:16Z","timestamp":1778937136139,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010903","name":"Key Programme","doi-asserted-by":"publisher","award":["2023TSGC0717"],"award-info":[{"award-number":["2023TSGC0717"]}],"id":[{"id":"10.13039\/501100010903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874294"],"award-info":[{"award-number":["81874294"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200989"],"award-info":[{"award-number":["82200989"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["ZR2024MH065"],"award-info":[{"award-number":["ZR2024MH065"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2510500"],"award-info":[{"award-number":["2024YFC2510500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmaceutical Science Advances"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.pscia.2026.100121","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:56:30Z","timestamp":1776354990000},"page":"100121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Fufang Huangbo Formula mitigates myeloproliferative neoplasms by activating p53\/p21 signaling axis and inhibiting STAT3 and NF-\u03baB signaling pathways"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9569-824X","authenticated-orcid":false,"given":"Mingjie","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8054-0442","authenticated-orcid":false,"given":"Yanxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengxue","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiqi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhida","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8522-4764","authenticated-orcid":false,"given":"Baobing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.pscia.2026.100121_bib1","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1056\/NEJMra1406186","article-title":"Myeloproliferative neoplasms","volume":"376","author":"Spivak","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.pscia.2026.100121_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5737\/23688076284262268","article-title":"Myeloproliferative neoplasms (MPNs) - part 1: an overview of the diagnosis and treatment of the \"classical\" MPNs","volume":"28","author":"Fowlkes","year":"2018","journal-title":"Can. Oncol. Nurs. J."},{"issue":"9","key":"10.1016\/j.pscia.2026.100121_bib3","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1182\/blood.2020008043","article-title":"Clinical insights into the origins of thrombosis in myeloproliferative neoplasms","volume":"137","author":"Moliterno","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.pscia.2026.100121_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41408-018-0054-y","article-title":"The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion","volume":"8","author":"Barbui","year":"2018","journal-title":"Blood Cancer J."},{"issue":"23","key":"10.1016\/j.pscia.2026.100121_bib5","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood-2017-06-782037","article-title":"Myeloproliferative neoplasms: from origins to outcomes","volume":"130","author":"Nangalia","year":"2017","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.pscia.2026.100121_bib6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/ajh.23295","article-title":"Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis","volume":"87","author":"Vaidya","year":"2012","journal-title":"Am. J. Hematol."},{"issue":"10","key":"10.1016\/j.pscia.2026.100121_bib7","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","article-title":"Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study","volume":"29","author":"Tefferi","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.pscia.2026.100121_bib8","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3389\/fimmu.2020.02093","article-title":"Remodeling the bone marrow microenvironment - a proposal for targeting pro-inflammatory contributors in MPN","volume":"11","author":"Jutzi","year":"2020","journal-title":"Front. Immunol."},{"issue":"14","key":"10.1016\/j.pscia.2026.100121_bib9","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood-2011-11-394775","article-title":"Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?","volume":"119","author":"Hasselbalch","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.pscia.2026.100121_bib10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.leukres.2012.10.020","article-title":"Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?","volume":"37","author":"Hasselbalch","year":"2013","journal-title":"Leuk. Res."},{"issue":"5","key":"10.1016\/j.pscia.2026.100121_bib11","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/leu.2016.12","article-title":"Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both","volume":"30","author":"Koschmieder","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.pscia.2026.100121_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100711","article-title":"Role of inflammation in the biology of myeloproliferative neoplasms","volume":"42","author":"Koschmieder","year":"2020","journal-title":"Blood Rev."},{"issue":"9","key":"10.1016\/j.pscia.2026.100121_bib13","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/s41588-023-01479-8","article-title":"Inflammation drives pressure on TP53 mutant clones in myeloproliferative neoplasms","volume":"55","author":"Benabid","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.pscia.2026.100121_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1196817","article-title":"Mutations, inflammation and phenotype of myeloproliferative neoplasms","volume":"13","author":"Hermouet","year":"2023","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.pscia.2026.100121_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.molcel.2013.12.002","article-title":"Cyclin-dependent kinase 6 is a chromatin-bound cofactor for NF-kappaB-dependent gene expression","volume":"53","author":"Handschick","year":"2014","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.pscia.2026.100121_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ccell.2017.11.009","article-title":"Dual targeting of oncogenic activation and inflammatory signaling increases therapeutic efficacy in myeloproliferative neoplasms","volume":"33","author":"Kleppe","year":"2018","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.pscia.2026.100121_bib17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1182\/bloodadvances.2018026450","article-title":"Defective negative regulation of toll-like receptor signaling leads to excessive TNF-\u03b1 in myeloproliferative neoplasm","volume":"3","author":"Lai","year":"2019","journal-title":"Blood Adv."},{"issue":"24","key":"10.1016\/j.pscia.2026.100121_bib18","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1182\/blood-2011-04-348144","article-title":"TNF\u03b1 facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms","volume":"118","author":"Fleischman","year":"2011","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.pscia.2026.100121_bib19","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1182\/bloodadvances.2021004438","article-title":"Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F-induced disease","volume":"5","author":"M\u00fcller","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.pscia.2026.100121_bib20","article-title":"Regulatory mechanisms of STAT3 in GBM and its impact on TMZ resistance","volume":"17","author":"Lv","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.pscia.2026.100121_bib21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/0113892029280454240214072212","article-title":"Effect of Calebin-A on critical genes related to NAFLD: a protein-protein interaction network and molecular docking study","volume":"25","author":"Mahmoudi","year":"2024","journal-title":"Curr. Genom."},{"key":"10.1016\/j.pscia.2026.100121_bib22","doi-asserted-by":"crossref","DOI":"10.2174\/0118761429287057240116040703","article-title":"A review of the dual role of MicroRNA-21 in cardiovascular diseases: risk factor or a potential therapeutic target","volume":"17","author":"Jafari-Nozad","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.pscia.2026.100121_bib23","article-title":"Protective effect of platycodin D on allergic rhinitis in mice through DPP4\/JAK2\/STAT3 pathway inhibition","volume":"17","author":"Jia","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.pscia.2026.100121_bib24","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1158\/2159-8290.CD-14-0736","article-title":"JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response","volume":"5","author":"Kleppe","year":"2015","journal-title":"Cancer Discov."},{"issue":"18","key":"10.1016\/j.pscia.2026.100121_bib25","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood.2019004095","article-title":"Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN","volume":"136","author":"Gleitz","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.pscia.2026.100121_bib26","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1038\/s41467-022-32928-3","article-title":"Interleukin-1 contributes to clonal expansion and progression of bone marrow fibrosis in JAK2V617F-induced myeloproliferative neoplasm","volume":"13","author":"Rahman","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.pscia.2026.100121_bib27","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1038\/s41467-022-32927-4","article-title":"Inhibition of interleukin-1beta reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm","volume":"13","author":"Rai","year":"2022","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.pscia.2026.100121_bib28","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1111\/jcmm.16587","article-title":"Phellodendrine promotes autophagy by regulating the AMPK\/mTOR pathway and treats ulcerative colitis","volume":"25","author":"Su","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.pscia.2026.100121_bib29","article-title":"Huangbai liniment accelerated wound healing by activating Nrf2 signaling in diabetes","volume":"2020","author":"Zhang","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"16","key":"10.1016\/j.pscia.2026.100121_bib30","first-page":"1519","article-title":"Protection of Compound Cortex Phellodendri Fluid on colonic mucosa of rats with ulcerative colitis","volume":"30","author":"Zhao","year":"2021","journal-title":"Chin. J. New Drugs"},{"key":"10.1016\/j.pscia.2026.100121_bib31","series-title":"Pharmacopoeia of People's Republic of China","year":"2020"},{"issue":"7","key":"10.1016\/j.pscia.2026.100121_bib32","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1182\/blood-2013-10-530832","article-title":"Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm","volume":"124","author":"Lamrani","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.pscia.2026.100121_bib33","article-title":"Fine-Tuning of cholesterol homeostasis controls Erythroid differentiation","volume":"9","author":"Lu","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.pscia.2026.100121_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41389-023-00457-3","article-title":"PELI1 and EGFR cooperate to promote breast cancer metastasis","volume":"12","author":"Qi","year":"2023","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.pscia.2026.100121_bib35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1172\/JCI94518","article-title":"Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms","volume":"128","author":"Zhao","year":"2018","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.pscia.2026.100121_bib36","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ccr.2010.05.015","article-title":"Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells","volume":"17","author":"Mullally","year":"2010","journal-title":"Cancer Cell"},{"issue":"16","key":"10.1016\/j.pscia.2026.100121_bib37","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood.2022017578","article-title":"Genetic basis and molecular profiling in myeloproliferative neoplasms","volume":"141","author":"Luque Paz","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.pscia.2026.100121_bib38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-021-01116-z","article-title":"Molecular pathogenesis of the myeloproliferative neoplasms","volume":"14","author":"Greenfield","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.pscia.2026.100121_bib40","first-page":"1187","article-title":"Ultra-short cyclic peptide Cy (RL-QN15) acts as a TLR4 antagonist to expedite oral ulcer healing","volume":"46","author":"Ru","year":"2025","journal-title":"Zool. Res."},{"issue":"18","key":"10.1016\/j.pscia.2026.100121_bib41","doi-asserted-by":"crossref","first-page":"19503","DOI":"10.1021\/acs.jmedchem.5c01734","article-title":"Cyclic heptapeptide FZ1 acts as an integrin \u03b1v\u03b23 agonist to facilitate diabetic skin wound healing by enhancing angiogenesis","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.pscia.2026.100121_bib42","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.24272\/j.issn.2095-8137.2024.134","article-title":"Peptide Cy (RL-QN15) accelerates hair regeneration in diabetic mice by binding to the Frizzled-7 receptor","volume":"45","author":"Wu","year":"2024","journal-title":"Zool. Res."},{"key":"10.1016\/j.pscia.2026.100121_bib43","doi-asserted-by":"crossref","unstructured":"Y. Li, Q. Jia, N. Liu, S. Yin, J. Wang, Y. Ding, Y. Yang, Y. Peng, Z. Ru, S. Zhang, B.e. Qi, J. Sun, L. He, Y. Wang, K. Guo, and X. Yang, Peptide RL-QN15 regulates functions of epidermal stem cells to accelerate skin wound regeneration via the FZD8\/\u03b2-Catenin axis, Exploration. n\/a(n\/a). 20240090. https:\/\/doi.org\/10.1002\/EXP.20240090.","DOI":"10.1002\/EXP.20240090"},{"key":"10.1016\/j.pscia.2026.100121_bib44","article-title":"First identification of an amphibian-derived peptide with anti-vascular aging activity","author":"Liu","year":"2026","journal-title":"Zool. Res."},{"key":"10.1016\/j.pscia.2026.100121_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2026.173231","article-title":"The self-assembling amphibian-derived peptide (RADA)4-FZ1 pioneers a novel therapeutic platform for diabetic skin wound management","volume":"530","author":"Fu","year":"2026","journal-title":"Chem. Eng. J."},{"issue":"4","key":"10.1016\/j.pscia.2026.100121_bib46","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/ni.3691","article-title":"Mechanisms and consequences of Jak-STAT signaling in the immune system","volume":"18","author":"Villarino","year":"2017","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.pscia.2026.100121_bib47","first-page":"1876","article-title":"DNA damage is able to induce senescence in tumor cells in vitro and in vivo","volume":"62","author":"te Poele","year":"2002","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.pscia.2026.100121_bib48","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","article-title":"Hallmarks of cellular senescence","volume":"28","author":"Hernandez-Segura","year":"2018","journal-title":"Trends Cell Biol."},{"issue":"5","key":"10.1016\/j.pscia.2026.100121_bib49","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","article-title":"Cell cycle regulation: p53-p21-RB signaling","volume":"29","author":"Engeland","year":"2022","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.pscia.2026.100121_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030420","article-title":"Role of p53 in the regulation of cellular senescence","volume":"10","author":"Mijit","year":"2020","journal-title":"Biomolecules"},{"issue":"15","key":"10.1016\/j.pscia.2026.100121_bib51","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1182\/blood-2012-02-410712","article-title":"Combination treatment in vitro with Nutlin, a small-molecule antagonist of MDM2, and pegylated interferon-alpha 2a specifically targets JAK2V617F-positive polycythemia vera cells","volume":"120","author":"Lu","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.pscia.2026.100121_bib52","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1182\/blood.2018893545","article-title":"Oral idasanutlin in patients with polycythemia vera","volume":"134","author":"Mascarenhas","year":"2019","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.pscia.2026.100121_bib53","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1038\/onc.2016.478","article-title":"Loss of p53 induces leukemic transformation in a murine model of Jak2 V617F-driven polycythemia vera","volume":"36","author":"Tsuruta-Kishino","year":"2017","journal-title":"Oncogene"},{"issue":"6255","key":"10.1016\/j.pscia.2026.100121_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa5612","article-title":"The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4","volume":"349","author":"Kang","year":"2015","journal-title":"Science"}],"container-title":["Pharmaceutical Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2773216926000140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2773216926000140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:48:31Z","timestamp":1778935711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2773216926000140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":53,"alternative-id":["S2773216926000140"],"URL":"https:\/\/doi.org\/10.1016\/j.pscia.2026.100121","relation":{},"ISSN":["2773-2169"],"issn-type":[{"value":"2773-2169","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fufang Huangbo Formula mitigates myeloproliferative neoplasms by activating p53\/p21 signaling axis and inhibiting STAT3 and NF-\u03baB signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Pharmaceutical Science Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pscia.2026.100121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Shandong University.","name":"copyright","label":"Copyright"}],"article-number":"100121"}}